Loading…
Reported covered position: Leg Asst, Kennedy; Leg Aide, Sen HELP Comm
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Preserving Patient Access to Home Infusion Act
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: THORN RUN PARTNERS
Medicare and Medicaid coverage for home infusion professional services. H.R.2172/S.1058 - Preserving Patient Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: THORN RUN PARTNERS
Medicare and Medicaid coverage for home infusion professional services. H.R.2172/S.1058 - Preserving Patient Access to Home Infusion Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
STERIS CORPORATION via THORN RUN PARTNERS
2026 · third_quarter · Q3
Issues related to the medical device industry and the safe sterilization of medical devices.
Issues related to medical sterilization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| INTERNATIONAL PACKAGED ICE ASSOCIATION |
| 31 |
| 2010–2017 |
| KENTUCKY COMMUNITY AND TECHNICAL COLLEGE SYSTEM | 31 | 2010–2017 |
| EXELIXIS | 30 | 2020–2026 |
| INSTITUTE FOR GENE THERAPIES | 30 | 2020–2026 |
| NATIONAL HOME INFUSION ASSOCIATION | 30 | 2019–2026 |
| XEROX BUSINESS SERVICES LLC AND ITS AFFILIATES | 30 | 2010–2016 |
| GLAUKOS CORPORATION | 28 | 2016–2026 |
| GLAXOSMITHKLINE LLC | 28 | 2017–2024 |
| LUNDBECK LLC | 27 | 2010–2016 |
| AMPLIFON USA | 25 | 2021–2026 |
| STERIS CORPORATION | 24 | 2021–2026 |
| AGRI-SERVICES AGENCY | 21 | 2010–2014 |
| PATIENT SERVICES INCORPORATED (PSI) | 21 | 2012–2017 |
| CITY OF GRESHAM | 20 | 2012–2017 |
| MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY | 20 | 2010–2013 |
| OREGON WAVE ENERGY TRUST | 18 | 2011–2015 |
| MULTNOMAH COUNTY | 17 | 2012–2015 |
| NOVO NORDISK, INC. | 17 | 2016–2019 |
| ADVANCED DRAINAGE SYSTEMS | 16 | 2013–2017 |
| ENCORE CAPITAL GROUP | 16 | 2013–2017 |
| HARMONY BIOSCIENCES | 15 | 2020–2023 |
| ELI LILLY AND COMPANY | 14 | 2021–2023 |
| ACESSA HEALTH INC. | 13 | 2018–2020 |
| AMERICAN FINANCIAL SERVICES ASSOCIATION (AFSA) | 13 | 2014–2016 |
| AVERITAS PHARMA, INC | 13 | 2019–2023 |
| Arbor Pharmaceuticals, LLC | 13 | 2015–2017 |
| COOPERSURGICAL, INC. | 13 | 2024–2026 |
| JTR STRATEGIES ON BEHALF OF JETBLUE AIRWAYS CORPORATION | 13 | 2019–2022 |
| NATIONAL ASSOCIATION FOR THE EMPLOYMENT OF PEOPLE WHO ARE BLIND (NAEPB) | 13 | 2021–2023 |
| PTC THERAPEUTICS, INC. | 13 | 2021–2023 |
| ROCHE DIAGNOSTICS | 13 | 2010–2012 |
| ASSOCIATION OF AIR MEDICAL SERVICES | 12 | 2023–2026 |
| AVIS BUDGET CAR RENTAL, LLC | 12 | 2024–2026 |
| PARTNERSHIP FOR PART D ACCESS (INFORMAL COALITION) | 12 | 2017–2021 |
| #NOTJUSTFATIGUE | 11 | 2024–2026 |
| LONG TERM CARE PHARMACY ALLIANCE | 11 | 2011–2013 |
| ALLIANCE FOR DRONE INNOVATION (INFORMAL) | 10 | 2018–2020 |
| DEPRESSION BIPOLAR SUPPORT ALLIANCE (DBSA) | 10 | 2015–2017 |
| MOYER FOUNDATION | 10 | 2014–2017 |
| PROFESSIONAL COMPOUNDING CENTERS OF AMERICA | 9 | 2020–2021 |
| ALORA PHARMACEUTICALS, LLC | 8 | 2024–2026 |
| AMERICAN HISTORICAL ASSOCIATION | 8 | 2025–2026 |
| AMERICAN MANAGED CARE, LLC | 8 | 2010–2011 |
| REVOLT TECHNOLOGY, LLC | 8 | 2011–2012 |
| THURGOOD MARSHALL ACADEMY | 8 | 2010–2011 |
| ALERE INC (FORMERLY INVERNESS MEDICAL INNOVATIONS INC ) | 6 | 2010 |
| ALLERGAN, INC. | 6 | 2011–2012 |
| BLACK WOMEN'S HEALTH IMPERATIVE | 6 | 2021–2022 |
| INSPIRION PHARMACEUTICALS, LLC | 6 | 2014–2015 |
| JETBLUE AIRWAYS CORPORATION | 6 | 2023–2024 |
| SECRETOME THERAPEUTICS | 6 | 2025–2026 |
| ALS UNITED | 5 | 2025–2026 |
| AMERICA'S PHYSICIAN GROUPS | 5 | 2022 |
| BLACKLINE, INC. | 5 | 2018–2019 |
| CARESOURCE MANAGEMENT GROUP CO | 5 | 2011–2012 |
| GHAZAL & ASSOCIATES LLC ON BEHALF OF NORTHERN ESSEX COMMUNITY COLLEGE | 5 | 2010 |
| MDVIP | 5 | 2010 |
| OFFICE FURNITURE MANUFACTURERS COALITION | 5 | 2010 |
| T-MOBILE USA, INC. | 5 | 2016–2017 |
| TERSERA THERAPEUTICS | 5 | 2021 |
| THERAGEN, INC. | 5 | 2024 |
| ACADIA HEALTHCARE, INC. | 4 | 2022 |
| COLLEGIUM PHARMACEUTICAL INC | 4 | 2021 |
| COMCAST CORPORATION | 4 | 2016 |
| Corium | 4 | 2024 |
| IMPRIVATA, INC. | 4 | 2016 |
| OWLET BABY CARE | 4 | 2021–2022 |
| SERENA POWER, LLC | 4 | 2025 |
| SUN KNOWLEDGE | 4 | 2011 |
| ASPIRE COMMODITIES LP | 3 | 2016 |
| CARGO AIRLINE ASSOCIATION | 3 | 2019–2020 |
| CHEMBIO DIAGNOSTICS, INC. | 3 | 2013 |
| CONDUENT INCORPORATED AND ITS AFFILIATES | 3 | 2017 |
| ELECTROCHEMICAL OXYGEN CONCEPTS, INC. (EO2 CONCEPTS) | 3 | 2012 |
| ENCORE GLOBAL INVESTMENT MANAGEMENT, LLC | 3 | 2013 |
| FEDEX CORPORATION | 3 | 2019–2020 |
| INCOMM HOLDINGS, INC. | 3 | 2014 |
| MONUMENT INC. | 3 | 2023 |
| NIQUAN ENERGY LLC | 3 | 2023 |
| Oregon Health and Science University | 3 | 2017 |
| TIMOTHY R RUPLI & ASSOCIATES INC ON BEHALF OF RUST CONSULTING INC | 3 | 2010 |
| VISITING NURSE SERVICE OF NEW YORK | 3 | 2013–2014 |
| ENVIRONMENTAL SYSTEMS PRODUCTS, INC. | 2 | 2010 |
| SOLEL BONEH | 2 | 2025–2026 |
| US NATURALS | 2 | 2015 |
| ATLAS AIR WORLDWIDE HOLDINGS | 1 | 2019 |
| LIVONGO | 1 | 2019 |
Preserving Patient Access to Home Infusion Act
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: THORN RUN PARTNERS
Medicare and Medicaid coverage for home infusion professional services. H.R.2172 - Preserving Patient Access to Home Infusion Act.
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act. S.4784/H.R.8800 - National Defense Authorization Act for FY2027.
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act.
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THORN RUN PARTNERS
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. H.R.5343 - Ensuring Patient Access to Critical Breakthrough Products Act.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THORN RUN PARTNERS
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. H.R.5343 - Ensuring Patient Access to Critical Breakthrough Products Act.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THORN RUN PARTNERS
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. H.R.5343 - Ensuring Patient Access to Critical Breakthrough Products Act.
Bipartisan IVF for Military Families Act
Client: COOPERSURGICAL, INC. · Firm: THORN RUN PARTNERS
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act. S.4784/H.R.8800 - National Defense Authorization Act for FY2027.
Bipartisan IVF for Military Families Act
Client: COOPERSURGICAL, INC. · Firm: THORN RUN PARTNERS
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act.
Bipartisan IVF for Military Families Act
Client: COOPERSURGICAL, INC. · Firm: THORN RUN PARTNERS
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act.
National Defense Authorization Act for Fiscal Year 2027
Client: COOPERSURGICAL, INC. · Firm: THORN RUN PARTNERS
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act. S.4784/H.R.8800 - National Defense Authorization Act for FY2027.
Preserving Patient Access to Home Infusion Act
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: THORN RUN PARTNERS
Medicare and Medicaid coverage for home infusion professional services. H.R.2172/S.1058 - Preserving Patient Access to Home Infusion Act.
Preserving Patient Access to Home Infusion Act
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: THORN RUN PARTNERS
Medicare and Medicaid coverage for home infusion professional services. H.R.2172/S.1058 - Preserving Patient Access to Home Infusion Act.
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act.
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act. S.4784/H.R.8800 - National Defense Authorization Act for FY2027.
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act.
National Defense Authorization Act for Fiscal Year 2027
Client: COOPERSURGICAL, INC. · Firm: THORN RUN PARTNERS
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act. S.4784/H.R.8800 - National Defense Authorization Act for FY2027.
Preserving Patient Access to Home Infusion Act
Client: NATIONAL HOME INFUSION ASSOCIATION · Firm: THORN RUN PARTNERS
Medicare and Medicaid coverage for home infusion professional services. H.R.2172 - Preserving Patient Access to Home Infusion Act.
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. S.2296 - National Defense Authorization Act for Fiscal Year 2026.
Ensuring Patient Access to Critical Breakthrough Products Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THORN RUN PARTNERS
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. H.R.5343 - Ensuring Patient Access to Critical Breakthrough Products Act.
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. S.2296 - National Defense Authorization Act for Fiscal Year 2026.
National Defense Authorization Act for Fiscal Year 2026
Client: COOPERSURGICAL, INC. · Firm: THORN RUN PARTNERS
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. S.2296 - National Defense Authorization Act for Fiscal Year 2026.
Healthcare Issues. H.R.2707 - MADE in America Act.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024
Client: CORIUM · Firm: THORN RUN PARTNERS
Issues related to ADHD issues and drug shortages. H.R.5893/S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024
Client: CORIUM · Firm: THORN RUN PARTNERS
Issues related to ADHD issues and drug shortages. H.R.5893/S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024.
Fertility. Maternal Health. S.3612/H.R.7056 - Access to Family Building Act.
Fertility. Maternal Health. Issues related to sperm donation. S.3612/H.R.7056 - Access to Family Building Act. S.4445 - Right to IVF Act. S.4368 - IVF Protection Act.
Fertility. Maternal Health. Issues related to sperm donation. S.3612/H.R.7056 - Access to Family Building Act. S.4445 - Right to IVF Act. S.4368 - IVF Protection Act.
Fertility. Maternal Health. Issues related to sperm donation. S.3612/H.R.7056 - Access to Family Building Act. S.4445 - Right to IVF Act. S.4368 - IVF Protection Act.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024
Client: CORIUM · Firm: THORN RUN PARTNERS
Issues related to ADHD issues and drug shortages. H.R.5893/S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024
Client: CORIUM · Firm: THORN RUN PARTNERS
Issues related to ADHD issues and drug shortages. H.R.5893/S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024.
Fertility. Maternal Health. S.3612/H.R.7056 - Access to Family Building Act.
Fertility. Maternal Health. Issues related to sperm donation. S.3612/H.R.7056 - Access to Family Building Act. S.4445 - Right to IVF Act. S.4368 - IVF Protection Act.
Fertility. Maternal Health. Issues related to sperm donation. S.3612/H.R.7056 - Access to Family Building Act. S.4445 - Right to IVF Act. S.4368 - IVF Protection Act.
Fertility. Maternal Health. Issues related to sperm donation. S.3612/H.R.7056 - Access to Family Building Act. S.4445 - Right to IVF Act. S.4368 - IVF Protection Act.
Fertility. Maternal Health. Issues related to sperm donation. S.3612/H.R.7056 - Access to Family Building Act. S.4445 - Right to IVF Act. S.4368 - IVF Protection Act.
Fertility. Maternal Health. Issues related to sperm donation. S.3612/H.R.7056 - Access to Family Building Act. S.4445 - Right to IVF Act. S.4368 - IVF Protection Act.
Fertility. Maternal Health. Issues related to sperm donation. S.3612/H.R.7056 - Access to Family Building Act. S.4445 - Right to IVF Act. S.4368 - IVF Protection Act.
Fertility. Maternal Health. Issues related to sperm donation. S.3612/H.R.7056 - Access to Family Building Act. S.4445 - Right to IVF Act. S.4368 - IVF Protection Act.
Fertility. Maternal Health. Issues related to sperm donation. S.3612/H.R.7056 - Access to Family Building Act. S.4445 - Right to IVF Act. S.4368 - IVF Protection Act.
Fertility. Maternal Health. Issues related to sperm donation. S.3612/H.R.7056 - Access to Family Building Act. S.4445 - Right to IVF Act. S.4368 - IVF Protection Act.
Issues related to regulatory and reimbursement policies for innovative gene therapies. H.R.7389 - MVP Act.
Issues related to regulatory and reimbursement policies for innovative gene therapies. H.R.7389 - MVP Act.
Issues related to regulatory and reimbursement policies for innovative gene therapies. H.R.7389 - MVP Act.
Issues related to regulatory and reimbursement policies for innovative gene therapies. H.R.7389 - MVP Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; and access to non-controlled medications. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1350, Camerons Law. H.R. 8295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act. H.R. 1805, The Rare Disease Clinical Trials Pandemic Disruption Act. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Issues related to Medicare Part D redesign.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830, S.1375 - The HELP Copays Act.
Access to Prescription Digital Therapeutics Act of 2023
Client: AVERITAS PHARMA, INC · Firm: THORN RUN PARTNERS
Monitor issues related to Medicare and Medicaid access to non-opioid treatment for chronic pain. H.R.1458 / S.723 - Access to Prescription Digital Therapeutics Act of 2023.
Access to Prescription Digital Therapeutics Act of 2023
Client: AVERITAS PHARMA, INC · Firm: THORN RUN PARTNERS
Issues related to Medicare and Medicaid access to non-opioid treatment for chronic pain. S.723: Access to Prescriptoin Digital Therapeutics Act of 2023. H.R.1458: Access to Prescription Digital Therapeutics Act of 2023.
Access to Prescription Digital Therapeutics Act of 2023
Client: AVERITAS PHARMA, INC · Firm: THORN RUN PARTNERS
Issues related to Medicare and Medicaid access to non-opioid treatment for chronic pain. H.R.1458 / S.723 - Access to Prescription Digital Therapeutics Act of 2023.
Access to Prescription Digital Therapeutics Act of 2023
Client: AVERITAS PHARMA, INC · Firm: THORN RUN PARTNERS
Issues related to Medicare and Medicaid access to non-opioid treatment for chronic pain. S.723: Access to Prescriptoin Digital Therapeutics Act of 2023. H.R.1458: Access to Prescription Digital Therapeutics Act of 2023.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830, S.1375 - The HELP Copays Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; and access to non-controlled medications. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1350, Camerons Law. H.R. 8295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act. H.R. 1805, The Rare Disease Clinical Trials Pandemic Disruption Act. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Issues related to Medicare Part D redesign.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830, S.1375 - The HELP Copays Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830, S.1375 - The HELP Copays Act.
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350 - Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805 - Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830/S.1375 - HELP Copays Act. H.R.5539 - ORPHAN Cures Act.
Access to Prescription Digital Therapeutics Act of 2023
Client: AVERITAS PHARMA, INC · Firm: THORN RUN PARTNERS
Issues related to Medicare and Medicaid access to non-opioid treatment for chronic pain. H.R.1458 / S.723 - Access to Prescription Digital Therapeutics Act of 2023.
Access to Prescription Digital Therapeutics Act of 2023
Client: AVERITAS PHARMA, INC · Firm: THORN RUN PARTNERS
Issues related to Medicare and Medicaid access to non-opioid treatment for chronic pain. S.723: Access to Prescriptoin Digital Therapeutics Act of 2023. H.R.1458: Access to Prescription Digital Therapeutics Act of 2023.
Access to Prescription Digital Therapeutics Act of 2023
Client: AVERITAS PHARMA, INC · Firm: THORN RUN PARTNERS
Monitor issues related to Medicare and Medicaid access to non-opioid treatment for chronic pain. H.R.1458 / S.723 - Access to Prescription Digital Therapeutics Act of 2023.
Access to Prescription Digital Therapeutics Act of 2023
Client: AVERITAS PHARMA, INC · Firm: THORN RUN PARTNERS
Issues related to Medicare and Medicaid access to non-opioid treatment for chronic pain. S.723: Access to Prescriptoin Digital Therapeutics Act of 2023. H.R.1458: Access to Prescription Digital Therapeutics Act of 2023.
Treat and Reduce Obesity Act of 2021
Client: ELI LILLY AND COMPANY · Firm: THORN RUN PARTNERS
Issues related to Medicare coverage of obesity treatments. S.596/H.R.1577 - Treat and Reduce Obesity Act of 2021.
Treat and Reduce Obesity Act of 2021
Client: ELI LILLY AND COMPANY · Firm: THORN RUN PARTNERS
Issues related to Medicare coverage of obesity treatments. S.596/H.R.1577 - Treat and Reduce Obesity Act of 2021.
Protecting Seniors Through Immunization Act of 2021
Client: GLAXOSMITHKLINE LLC · Firm: THORN RUN PARTNERS
General health care coverage and reimbursement. Implementation issues regarding the Patient Protection and Affordable Care Act. Legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement. Food and Drug Administration legislative and regulatory issues. Implementation issues regarding the Inflation Reduction Act. H.R.1978/S.912 - Protecting Seniors Through Immunization Act of 2021.
Protecting Seniors Through Immunization Act of 2021
Client: GLAXOSMITHKLINE LLC · Firm: THORN RUN PARTNERS
General health care coverage and reimbursement. Implementation issues regarding the Patient Protection and Affordable Care Act. Legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement. Food and Drug Administration legislative and regulatory issues. Implementation issues regarding the Inflation Reduction Act. H.R.1978/S.912 - Protecting Seniors Through Immunization Act of 2021.
Protecting Seniors Through Immunization Act of 2021
Client: GLAXOSMITHKLINE LLC · Firm: THORN RUN PARTNERS
General health care coverage and reimbursement. Implementation issues regarding the Patient Protection and Affordable Care Act. Legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement. Food and Drug Administration legislative and regulatory issues. Implementation issues regarding the Inflation Reduction Act. H.R.1978/S.912 - Protecting Seniors Through Immunization Act of 2021.
Protecting Seniors Through Immunization Act of 2021
Client: GLAXOSMITHKLINE LLC · Firm: THORN RUN PARTNERS
General health care coverage and reimbursement. Implementation issues regarding the Patient Protection and Affordable Care Act. Legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement. Food and Drug Administration legislative and regulatory issues. Implementation issues regarding the Inflation Reduction Act. H.R.1978/S.912 - Protecting Seniors Through Immunization Act of 2021.
Issues related to regulatory and reimbursement policies for innovative gene therapies. H.R.7389 - MVP Act.
Issues related to regulatory and reimbursement policies for innovative gene therapies. H.R.7389 - MVP Act.
Issues related to regulatory and reimbursement policies for innovative gene therapies. H.R.7389 - MVP Act.
Issues related to regulatory and reimbursement policies for innovative gene therapies. H.R.7389 - MVP Act.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
Client: HARMONY BIOSCIENCES · Firm: THORN RUN PARTNERS
Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; and access to non-controlled medications. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1350, Camerons Law. H.R. 8295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act. H.R. 1805, The Rare Disease Clinical Trials Pandemic Disruption Act. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Issues related to Medicare Part D redesign.
Issues related to Medicare coverage of obesity treatments. S.596/H.R.1577 - Treat and Reduce Obesity Act of 2021.
Issues related to Medicare coverage of obesity treatments. S.596/H.R.1577 - Treat and Reduce Obesity Act of 2021.
Protecting Seniors Through Immunization Act of 2021
Client: GLAXOSMITHKLINE LLC · Firm: THORN RUN PARTNERS
General health care coverage and reimbursement. Implementation issues regarding the Patient Protection and Affordable Care Act. Legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement. Food and Drug Administration legislative and regulatory issues. Implementation issues regarding the Inflation Reduction Act. H.R.1978/S.912 - Protecting Seniors Through Immunization Act of 2021.
Protecting Seniors Through Immunization Act of 2021
Client: GLAXOSMITHKLINE LLC · Firm: THORN RUN PARTNERS
General health care coverage and reimbursement. Implementation issues regarding the Patient Protection and Affordable Care Act. Legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement. Food and Drug Administration legislative and regulatory issues. Implementation issues regarding the Inflation Reduction Act. H.R.1978/S.912 - Protecting Seniors Through Immunization Act of 2021.
Protecting Seniors Through Immunization Act of 2021
Client: GLAXOSMITHKLINE LLC · Firm: THORN RUN PARTNERS
General health care coverage and reimbursement. Implementation issues regarding the Patient Protection and Affordable Care Act. Legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement. Food and Drug Administration legislative and regulatory issues. Implementation issues regarding the Inflation Reduction Act. H.R.1978/S.912 - Protecting Seniors Through Immunization Act of 2021.
Protecting Seniors Through Immunization Act of 2021
Client: GLAXOSMITHKLINE LLC · Firm: THORN RUN PARTNERS
General health care coverage and reimbursement. Implementation issues regarding the Patient Protection and Affordable Care Act. Legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement. Food and Drug Administration legislative and regulatory issues. Implementation issues regarding the Inflation Reduction Act. H.R.1978/S.912 - Protecting Seniors Through Immunization Act of 2021.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: STERIS CORPORATION · Firm: THORN RUN PARTNERS
Device Servicing Act. Issues related to the medical device industry and the safe sterilization of medical devices. Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031. Issues related to the Prescription Drug User Fee Act (PDUFA).
Treat and Reduce Obesity Act of 2021
Client: ELI LILLY AND COMPANY · Firm: THORN RUN PARTNERS
Issues related to Medicare coverage of obesity treatments. S.596/H.R. 1577 - Treat and Reduce Obesity Act of 2021.
Treat and Reduce Obesity Act of 2021
Client: ELI LILLY AND COMPANY · Firm: THORN RUN PARTNERS
Issues related to Medicare coverage of obesity treatments. S.596/H.R. 1577, The Treat and Reduce Obesity Act.
Treat and Reduce Obesity Act of 2021
Client: ELI LILLY AND COMPANY · Firm: THORN RUN PARTNERS
Issues related to Medicare coverage of obesity treatments. S.596/H.R. 1577, The Treat and Reduce Obesity Act.
Treat and Reduce Obesity Act of 2021
Client: ELI LILLY AND COMPANY · Firm: THORN RUN PARTNERS
Issues related to Medicare coverage of obesity treatments. S.596/H.R. 1577, The Treat and Reduce Obesity Act.
Treat and Reduce Obesity Act of 2021
Client: ELI LILLY AND COMPANY · Firm: THORN RUN PARTNERS
Issues related to Medicare coverage of obesity treatments. S.596/H.R. 1577, The Treat and Reduce Obesity Act.
Treat and Reduce Obesity Act of 2021
Client: ELI LILLY AND COMPANY · Firm: THORN RUN PARTNERS
Issues related to Medicare coverage of obesity treatments. S.596/H.R. 1577 - Treat and Reduce Obesity Act of 2021.
2026 · third_quarter · Q3
Education related to neonatal stem cell research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2026 · third_quarter · Q3
Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via THORN RUN PARTNERS
2026 · third_quarter · Q3
Medicare and Medicaid coverage for home infusion professional services. H.R.2172/S.1058 - Preserving Patient Access to Home Infusion Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THORN RUN PARTNERS
2026 · third_quarter · Q3
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. H.R.5343 - Ensuring Patient Access to Critical Breakthrough Products Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSTITUTE FOR GENE THERAPIES via THORN RUN PARTNERS
2026 · third_quarter · Q3
Issues related to regulatory and reimbursement policies for innovative gene therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GLAUKOS CORPORATION via THORN RUN PARTNERS
2026 · third_quarter · Q3
Corporate tax issues.
Issues related to treatments for eye diseases.
Issues related to treatments for eye diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAUKOS CORPORATION via THORN RUN PARTNERS
2026 · third_quarter · Q3
Issues related to treatments for eye diseases.
Corporate tax issues.
Issues related to treatments for eye diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS via THORN RUN PARTNERS
2026 · third_quarter · Q3
Policies related to creating incentives for innovation in the life sciences.
Tracking implementation of prescription drug pricing policies included as part of the Inflation Reduction Act (IRA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COOPERSURGICAL, INC. via THORN RUN PARTNERS
2026 · third_quarter · Q3
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act. S.4784/H.R.8800 - National Defense Authorization Act for FY2027.
IVF tax credit legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Labor, Dept of (DOL), SENATE, White House Office
CONTINUING MEDICAL EDUCATION COALITION via THORN RUN PARTNERS
2026 · third_quarter · Q3
Issues related to provision of continuing medical education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via THORN RUN PARTNERS
2026 · third_quarter · Q3
Policies related to creating incentives for innovation in the life sciences.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVIS BUDGET CAR RENTAL, LLC via THORN RUN PARTNERS
2026 · third_quarter · Q3
Issues related to the rental car industry.
Issues related to the rental car industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMPLIFON USA via THORN RUN PARTNERS
2026 · third_quarter · Q3
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HISTORICAL ASSOCIATION via THORN RUN PARTNERS
2026 · third_quarter · Q3
Teaching and learning of American History, preservation and access, archives, curriculum reform, political history.
Teaching and learning of American History, preservation and access, archives, curriculum reform, political history.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALS UNITED via THORN RUN PARTNERS
2026 · third_quarter · Q3
Support for ALS research and treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALORA PHARMACEUTICALS, LLC via THORN RUN PARTNERS
2026 · third_quarter · Q3
Healthcare issues, related to domestic manufacturing. Desiccated thyroid extract (DTE) medications.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
#NOTJUSTFATIGUE via THORN RUN PARTNERS
2026 · third_quarter · Q3
Federal support to address chronic fatigue syndrome.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSTITUTE FOR GENE THERAPIES via THORN RUN PARTNERS
2026 · second_quarter · Q2
Issues related to regulatory and reimbursement policies for innovative gene therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS via THORN RUN PARTNERS
2026 · second_quarter · Q2
Policies related to creating incentives for innovation in the life sciences.
Tracking implementation of prescription drug pricing policies included as part of the Inflation Reduction Act (IRA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2026 · second_quarter · Q2
Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THORN RUN PARTNERS
2026 · second_quarter · Q2
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. H.R.5343 - Ensuring Patient Access to Critical Breakthrough Products Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COOPERSURGICAL, INC. via THORN RUN PARTNERS
2026 · second_quarter · Q2
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Labor, Dept of (DOL), SENATE, White House Office
ALS UNITED via THORN RUN PARTNERS
2026 · second_quarter · Q2
Support for ALS research and treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALORA PHARMACEUTICALS, LLC via THORN RUN PARTNERS
2026 · second_quarter · Q2
Healthcare issues, related to domestic manufacturing. Desiccated thyroid extract (DTE) medications.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
STERIS CORPORATION via THORN RUN PARTNERS
2026 · second_quarter · Q2
Issues related to the medical device industry and the safe sterilization of medical devices.
Issues related to medical sterilization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SECRETOME THERAPEUTICS via THORN RUN PARTNERS
2026 · second_quarter · Q2
Education related to neonatal stem cell research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via THORN RUN PARTNERS
2026 · second_quarter · Q2
Medicare and Medicaid coverage for home infusion professional services. H.R.2172/S.1058 - Preserving Patient Access to Home Infusion Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAUKOS CORPORATION via THORN RUN PARTNERS
2026 · second_quarter · Q2
Issues related to treatments for eye diseases.
Corporate tax issues.
Issues related to treatments for eye diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONTINUING MEDICAL EDUCATION COALITION via THORN RUN PARTNERS
2026 · second_quarter · Q2
Issues related to provision of continuing medical education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via THORN RUN PARTNERS
2026 · second_quarter · Q2
Policies related to creating incentives for innovation in the life sciences.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVIS BUDGET CAR RENTAL, LLC via THORN RUN PARTNERS
2026 · second_quarter · Q2
Issues related to the rental car industry.
Issues related to the rental car industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMPLIFON USA via THORN RUN PARTNERS
2026 · second_quarter · Q2
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HISTORICAL ASSOCIATION via THORN RUN PARTNERS
2026 · second_quarter · Q2
Teaching and learning of American History, preservation and access, archives, curriculum reform, political history.
Teaching and learning of American History, preservation and access, archives, curriculum reform, political history.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
#NOTJUSTFATIGUE via THORN RUN PARTNERS
2026 · second_quarter · Q2
Federal support to address chronic fatigue syndrome.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STERIS CORPORATION via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues related to medical sterilization.
Issues related to the medical device industry and the safe sterilization of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLEL BONEH via THORN RUN PARTNERS
2026 · first_quarter · 1T
Education related to Israeli energy infrastructure project.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES
SECRETOME THERAPEUTICS via THORN RUN PARTNERS
2026 · first_quarter · Q1
Education related to neonatal stem cell research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via THORN RUN PARTNERS
2026 · first_quarter · Q1
Medicare and Medicaid coverage for home infusion professional services. H.R.2172 - Preserving Patient Access to Home Infusion Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. H.R.5343 - Ensuring Patient Access to Critical Breakthrough Products Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSTITUTE FOR GENE THERAPIES via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues related to regulatory and reimbursement policies for innovative gene therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSTITUTE FOR GENE THERAPIES via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues related to regulatory and reimbursement policies for innovative gene therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GLAUKOS CORPORATION via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues related to treatments for eye diseases.
Issues related to treatments for eye diseases.
Corporate tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS via THORN RUN PARTNERS
2026 · first_quarter · Q1
Tracking implementation of prescription drug pricing policies included as part of the Inflation Reduction Act (IRA).
Policies related to creating incentives for innovation in the life sciences.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COOPERSURGICAL, INC. via THORN RUN PARTNERS
2026 · first_quarter · Q1
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. H.R.6797 - Bipartisan IVF for Military Families Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
CONTINUING MEDICAL EDUCATION COALITION via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues related to provision of continuing medical education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via THORN RUN PARTNERS
2026 · first_quarter · Q1
Policies related to creating incentives for innovation in the life sciences.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVIS BUDGET CAR RENTAL, LLC via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues related to the rental car industry.
Issues related to the rental car industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AIR MEDICAL SERVICES via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues related to Medicare reimbursement of air ambulance services. Implementation of the No Surprises Act.
Issues related to the Federal Aviation Administration Reauthorization.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMPLIFON USA via THORN RUN PARTNERS
2026 · first_quarter · Q1
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HISTORICAL ASSOCIATION via THORN RUN PARTNERS
2026 · first_quarter · Q1
Teaching and learning of American History, preservation and access, archives, curriculum reform, political history.
Teaching and learning of American History, preservation and access, archives, curriculum reform, political history.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALS UNITED via THORN RUN PARTNERS
2026 · first_quarter · Q1
Support for ALS research and treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALORA PHARMACEUTICALS, LLC via THORN RUN PARTNERS
2026 · first_quarter · Q1
Healthcare issues, related to domestic manufacturing. Desiccated thyroid extract (DTE) medications.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
#NOTJUSTFATIGUE via THORN RUN PARTNERS
2026 · first_quarter · Q1
Federal support to address chronic fatigue syndrome.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STERIS CORPORATION via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Issues related to the medical device industry and the safe sterilization of medical devices.
Issues related to medical sterilization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COOPERSURGICAL, INC. via THORN RUN PARTNERS
2025 · fourth_quarter · 4A
Fertility. IVF. Maternal Health. S.1231/H.R.2557 - IVF for Military Families Act. S.2296 - National Defense Authorization Act for Fiscal Year 2026.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
INSTITUTE FOR GENE THERAPIES via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Issues related to regulatory and reimbursement policies for innovative gene therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GLAUKOS CORPORATION via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Issues related to treatments for eye diseases.
Issues related to treatments for eye diseases.
Corporate tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Policies related to creating incentives for innovation in the life sciences.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMPLIFON USA via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. H.R.5343 - Ensuring Patient Access to Critical Breakthrough Products Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALS UNITED via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Support for ALS research and treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
#NOTJUSTFATIGUE via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Federal support to address chronic fatigue syndrome.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SECRETOME THERAPEUTICS via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Education related to neonatal stem cell research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Policies related to creating incentives for innovation in the life sciences.
Tracking implementation of prescription drug pricing policies included as part of the Inflation Reduction Act (IRA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLEL BONEH via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Education related to Israeli energy infrastructure project.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES
NATIONAL HOME INFUSION ASSOCIATION via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Medicare and Medicaid coverage for home infusion professional services. H.R.2172 - Preserving Patient Access to Home Infusion Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COOPERSURGICAL, INC. via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Fertility. IVF. Maternal Health.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ALORA PHARMACEUTICALS, LLC via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Healthcare issues, related to domestic manufacturing. Desiccated thyroid extract (DTE) medications.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SERENA POWER, LLC via THORN RUN PARTNERS
2025 · fourth_quarter · 4T
Wind energy production.
Wind energy production.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVIS BUDGET CAR RENTAL, LLC via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Issues related to the rental car industry.
Issues related to the rental car industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AIR MEDICAL SERVICES via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Issues related to the Federal Aviation Administration Reauthorization.
Issues related to Medicare reimbursement of air ambulance services. Implementation of the No Surprises Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HISTORICAL ASSOCIATION via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Teaching and learning of American History, preservation and access, archives, curriculum reform, political history.
Teaching and learning of American History, preservation and access, archives, curriculum reform, political history.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONTINUING MEDICAL EDUCATION COALITION via THORN RUN PARTNERS
2025 · fourth_quarter · Q4
Issues related to provision of continuing medical education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALS UNITED via THORN RUN PARTNERS
2025 · fourth_quarter · RR
Support for ALS research and treatment.
STERIS CORPORATION via THORN RUN PARTNERS
2025 · third_quarter · Q3
Issues related to the medical device industry and the safe sterilization of medical devices.
Issues related to medical sterilization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SERENA POWER, LLC via THORN RUN PARTNERS
2025 · third_quarter · Q3
Wind energy production.
Wind energy production.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SECRETOME THERAPEUTICS via THORN RUN PARTNERS
2025 · third_quarter · Q3
Education related to neonatal stem cell research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2025 · third_quarter · Q3
Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HOME INFUSION ASSOCIATION via THORN RUN PARTNERS
2025 · third_quarter · Q3
Medicare and Medicaid coverage for home infusion professional services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THORN RUN PARTNERS
2025 · third_quarter · Q3
Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INSTITUTE FOR GENE THERAPIES via THORN RUN PARTNERS
2025 · third_quarter · Q3
Issues related to regulatory and reimbursement policies for innovative gene therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GLAUKOS CORPORATION via THORN RUN PARTNERS
2025 · third_quarter · Q3
Issues related to treatments for eye diseases.
Issues related to treatments for eye diseases.
Corporate tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS via THORN RUN PARTNERS
2025 · third_quarter · Q3
Policies related to creating incentives for innovation in the life sciences.
Tracking implementation of prescription drug pricing policies included as part of the Inflation Reduction Act (IRA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COOPERSURGICAL, INC. via THORN RUN PARTNERS
2025 · third_quarter · Q3
Fertility. IVF. Maternal Health.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CONTINUING MEDICAL EDUCATION COALITION via THORN RUN PARTNERS
2025 · third_quarter · Q3
Issues related to provision of continuing medical education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via THORN RUN PARTNERS
2025 · third_quarter · Q3
Policies related to creating incentives for innovation in the life sciences.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVIS BUDGET CAR RENTAL, LLC via THORN RUN PARTNERS
2025 · third_quarter · Q3
Issues related to the rental car industry.
Issues related to the rental car industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AIR MEDICAL SERVICES via THORN RUN PARTNERS
2025 · third_quarter · Q3
Issues related to the Federal Aviation Administration Reauthorization.
Issues related to Medicare reimbursement of air ambulance services. Implementation of the No Surprises Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMPLIFON USA via THORN RUN PARTNERS
2025 · third_quarter · Q3
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
Issues regarding coverage of hearing aids under Medicare and Medicaid. Issues related to hearing health. Issues related to FDA regulation of over the counter (OTC) hearing aids.
AMERICAN HISTORICAL ASSOCIATION via THORN RUN PARTNERS
2025 · third_quarter · Q3
Teaching and learning of American History, preservation and access, archives, curriculum reform, political history.
Teaching and learning of American History, preservation and access, archives, curriculum reform, political history.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALORA PHARMACEUTICALS, LLC via THORN RUN PARTNERS
2025 · third_quarter · Q3
Healthcare issues, related to domestic manufacturing. Desiccated thyroid extract (DTE) medications.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
#NOTJUSTFATIGUE via THORN RUN PARTNERS
2025 · third_quarter · Q3
Federal support to address chronic fatigue syndrome.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SECRETOME THERAPEUTICS via THORN RUN PARTNERS
2025 · third_quarter · RR
Education related to neonatal stem cell research.
INSTITUTE FOR GENE THERAPIES via THORN RUN PARTNERS
2025 · second_quarter · 2A
Issues related to regulatory and reimbursement policies for innovative gene therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
STERIS CORPORATION via THORN RUN PARTNERS
2025 · second_quarter · Q2
Issues related to the medical device industry and the safe sterilization of medical devices.
Issues related to medical sterilization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC AIRLINES, INC. via THORN RUN PARTNERS
2025 · second_quarter · Q2
FAA Reauthorization. Issues related to pilot training.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSTITUTE FOR GENE THERAPIES via THORN RUN PARTNERS
2025 · second_quarter · Q2
Issues related to regulatory and reimbursement policies for innovative gene therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE